Jiahe Biotech (6998.HK): Focus on seeking differentiated pipeline layout amid intensifying competition for cancer immune cycles
Jiahe Biology (6998.HK)
Jiahe Biology-B (06998.HK): IPO
IPO News: Jiahe Biopharmaceutical (Cayman) Holdings Limited-B (06998.HK)
Jiahe Biotech (H01388.): The breast cancer circuit layout is comprehensive and the innovative drug pipeline will usher in a harvest period
No Data